ka mālama ʻana i ka maʻi maʻi ʻaʻai adenocarcinoma

ʻO Adenocarcinoma ke ʻano maʻamau o ka maʻi kanesa maʻi. ʻO nā koho lapaʻau e pili ana i nā kumu he nui, me ka pae o ka maʻi kanesa, ke olakino holoʻokoʻa o ka mea maʻi, a me nā makemake pilikino. Hāʻawi kēia alakaʻi i kahi ʻike kikoʻī o nā ʻano like ʻole ka mālama ʻana i ka maʻi maʻi ʻaʻai adenocarcinoma nā koho i loaʻa, e hāʻawi ana i nā ʻike i ko lākou pono a me nā hopena ʻaoʻao.Adenocarcinoma He ʻano ia o ka maʻi maʻi ʻaʻai ʻāʻī liʻiliʻi liʻiliʻi (NSCLC) e hoʻomaka ana i loko o nā pūnaewele e hoʻohua ai i ka mucus i loko o ka māmā. Loaʻa pinepine ia ma nā ʻāpana o waho o ka māmā. He mea koʻikoʻi ka ʻike mua ʻana no ka maikaʻi ka mālama ʻana i ka maʻi maʻi ʻaʻai adenocarcinoma. ʻO ka Shandong Baofa Cancer Research Institute ua kūpaʻa ʻo ia i ka holomua ʻana i ka ʻike a me ka mālama ʻana i kēia maʻi paʻakikī. ʻO nā mea pilikia no ka Adenocarcinoma ʻOiai ʻo ka puhi ʻana he kumu pilikia nui ia no nā ʻano maʻi maʻi maʻi maʻi. adenocarcinoma ʻike pinepine ʻia i ka poʻe puhi paka ʻole ma mua o nā ʻano ʻē aʻe. ʻO nā kumu pilikia ʻē aʻe: ʻO ka hoʻolaha ʻana i ke kinoea radon Ka ʻike ʻana i ka asbestos Moʻolelo ʻohana o ka maʻi maʻi maʻi maʻi maʻi maʻi maʻi ea. adenocarcinoma, me: X-ray o ka umauma: Hāʻawi i kahi kiʻi mua o ka māmā. CT Scan: Hoʻokumu i nā kiʻi kikoʻī o ka māmā a me nā ʻiʻo a puni. PET scan: Kōkua i ka ʻike ʻana i nā wahi o ka hoʻonui ʻana i ka hana metabolic, e hōʻike ana i ka maʻi kanesa. Bronchoscopy: Hāʻawi i nā kauka e nānā i nā ala ea a hōʻiliʻili i nā laʻana kiko. Biopsy: Nānā ʻia kahi laʻana kiko ma lalo o kahi microscope e hōʻoia i ka maʻi. ka mālama ʻana i ka maʻi maʻi ʻaʻai adenocarcinoma. Hoʻokumu ʻia ke kahua ma: T (Tumo): Ka nui a me ka wahi o ka ma'i koko mua. N (Nā helu): Ua laha paha ka ma'i 'a'ai i nā pūnana lymph kokoke. M (Metastasis): Ua laha paha ka ma'i 'a'ai i na kino mamao. Mai ka Stage 0 (cancer in situ) a i ka Stage IV (metastatic cancer). Adenocarcinoma Lung Cancer Treatment OptionsThe best ka mālama ʻana i ka maʻi maʻi ʻaʻai adenocarcinoma pili ka papahana i ke kahua, ke olakino holoʻokoʻa o ka mea maʻi, a me kā lākou makemake. ʻO nā koho lapaʻau maʻamau, penei: ʻO ka ʻokiʻoki ʻana ke manaʻo e wehe i ka maʻi maʻi ʻaʻai a me nā ʻiʻo e puni ana. ʻO nā koho ʻokiʻoki he: Wedge Resection: ʻO ka wehe ʻana i kahi ʻāpana māmā liʻiliʻi me ke ʻano wili. Lobectomy: Ka wehe ʻana i kahi lobe holoʻokoʻa o ka māmā. Pneumonectomy: Ka wehe ʻana i kahi māmā holoʻokoʻa. Manaʻo pinepine ʻia ka ʻoki ʻana no ka wā mua ka mālama ʻana i ka maʻi maʻi ʻaʻai adenocarcinoma i ka wā e ʻike ʻia ai ka maʻi maʻi a ua lawa ke olakino o ka mea maʻi e hana i ke kaʻina hana. Hiki ke hoʻohana: Ma ke ʻano he lapaʻau mua: No nā poʻe maʻi ʻaʻole hiki ke hoʻopaʻa ʻia. Ma hope o ka ʻoki ʻana: No ka pepehi ʻana i nā keʻena maʻi kanesa i koe. E hoʻomaha i nā hōʻailona: E like me ka ʻeha a i ʻole ka pōkole o ka hanu. ʻO nā ʻano o ka radiation therapy kekahi: ʻO ka hoʻomaʻamaʻa ʻana i ka lāʻau lapaʻau waho (EBRT): Hāʻawi ʻia ka radiation mai kahi mīkini ma waho o ke kino. ʻO ka hoʻomaʻamaʻa ʻana o ke kino stereootactic (SBRT): Hāʻawi i nā kiʻekiʻe kiʻekiʻe o ka radiation i kahi wahi liʻiliʻi.ChemotherapyChemotherapy hoʻohana i nā lāʻau lapaʻau e pepehi i nā maʻi maʻi maʻi a puni ke kino. Hoʻohana pinepine ʻia: Ma mua o ka ʻoki ʻana: No ka hōʻemi ʻana i ke koko (neoadjuvant chemotherapy). Ma hope o ka ʻoki ʻana: No ka pepehi ʻana i nā keʻena maʻi kanesa i koe (adjuvant chemotherapy). Ma ke ʻano he lapaʻau mua: No ka pae kiʻekiʻe adenocarcinoma.ʻO nā lāʻau lapaʻau maʻamau i hoʻohana ʻia e mālama adenocarcinoma e komo pū me cisplatin, carboplatin, pemetrexed, a me docetaxel.Targeted Therapy ʻO nā lāʻau lapaʻau i hoʻopaʻa ʻia e hoʻopaʻa i nā molekole kikoʻī (e laʻa, nā protein, nā genes) e pili ana i ka ulu ʻana o ka maʻi kanesa a me ke ola. Hoʻohana pinepine ʻia kēia mau lāʻau lapaʻau no adenocarcinoma me nā hoʻololi genetic kikoʻī. ʻO nā laʻana o nā lāʻau lapaʻau i kuhikuhi ʻia: EGFR inhibitors: Erlotinib, gefitinib, afatinib, osimertinib (no nā hoʻololi EGFR) ʻO nā mea pale ALK: Crizotinib, alectinib, ceritinib, brigatinib, lorlatinib (no ka hoʻonohonoho hou ʻana o ALK) ʻO nā mea hoʻopaneʻe ROS1: Crizotinib, entrectinib (no ka hoʻonohonoho hou ʻana o ROS1) ʻO nā mea pale BRAF: ʻO Dabrafenib, trametinib (no ka hoʻololi ʻana o BRAF) He mea koʻikoʻi ka hoʻāʻo ʻana i ka genetic e hoʻoholo ai inā kūpono ka mea maʻi no ka lāʻau lapaʻau. ʻO ka Shandong Baofa Cancer Research Institute hōʻike i ka pono o ka lāʻau lapaʻau pilikino i ka mālama ʻana i ka maʻi maʻi ʻaʻai adenocarcinoma.ImmunotherapyImmunotherapy nā lāʻau lapaʻau e kōkua i ke kino o ke kino e hakakā i ka maʻi kanesa. Hana lākou ma ka pale ʻana i nā protein e pale ai i ka ʻōnaehana pale mai ka hoʻouka ʻana i nā maʻi maʻi maʻi. ʻO nā mea hoʻopale PD-1: Pembrolizumab, nivolumab ʻO nā mea hoʻopaneʻe PD-L1: Hoʻohana pinepine ʻia ʻo Atezolizumab, durvalumabImmunotherapy no ka pae kiʻekiʻe adenocarcinoma, i ka manawa e hōʻike ai nā pūnaewele maʻi kanesa i ka PD-L1. Nā hopena ʻaoʻao o ka Lapaʻau ʻanaAll ka mālama ʻana i ka maʻi maʻi ʻaʻai adenocarcinoma hiki i nā koho ke hana i nā hopena ʻaoʻao. ʻO nā hopena ʻaoʻao kikoʻī e pili ana i ke ʻano o ka mālama ʻana, ka nui, a me ka pane pilikino o ka mea maʻi. Loaʻa nā hopena ʻaoʻao maʻamau: ʻO ka luhi Nausea a me ka luaʻi ʻana ʻO ka lauoho ʻeha ʻeha waha Ka pau ʻana o ka ʻai Nawaliwali ka ʻōnaehana pale He mea nui e kūkākūkā i nā hopena ʻaoʻao me kāu kauka a hoʻomohala i kahi hoʻolālā e hoʻokele iā lākou. ʻO ka Shandong Baofa Cancer Research Institute's ʻO ka lāʻau lapaʻau e pili ana i ka hōʻemi ʻana i nā hopena ʻaoʻao aʻo ka hoʻonui ʻana i ka pono. ka mālama ʻana i ka maʻi maʻi ʻaʻai adenocarcinoma hoʻokokoke. Hiki i nā maʻi ke noʻonoʻo e komo i kahi hoʻokolohua lapaʻau no ke komo ʻana i nā lāʻau lapaʻau hou ʻaʻole i loaʻa ākea. E aʻo hou e pili ana i ka noiʻi ʻana i ka maʻi maʻi maʻi ma Shandong Baofa Cancer Research Institute.Ka wānana a me ke ola ʻana ka wānana no adenocarcinoma pili i kekahi mau kumu, e like me ka pae o ka maʻi kanesa, ke olakino holoʻokoʻa o ka mea maʻi, a me ka pane ʻana i ka lāʻau lapaʻau. Hiki i ka ʻike mua ʻana a me ka mālama ʻana ke hoʻomaikaʻi maikaʻi i nā helu ola. ʻO ka nui o ke ola ola ʻana no ka maʻi kanesa o ka maʻi maʻi i hōʻike pinepine ʻia ma ke ʻano he 5 mau makahiki ola ola, ʻo ia hoʻi ka pākēneka o ka poʻe e ola nei i ʻelima mau makahiki ma hope o ka hōʻoia ʻana. Wahi a ka American Cancer Society, he 25% ka helu ola o 5 makahiki no nā pae āpau o ka maʻi kanesa. Eia nō naʻe, ʻokoʻa kēia helu ma muli o ke kahua o ka maʻi maʻi. No ka laʻana, ʻoi aku ka kiʻekiʻe o ka helu ola 5 makahiki no ka maʻi kanesa āpau (ka maʻi kanesa ʻaʻole i laha ma waho o ka māmā) ʻoi aku ka kiʻekiʻe ma mua o ka maʻi kanesa maʻi maʻi metastatic (ka maʻi kanesa i laha i nā ʻōpū mamao). [Kumu: American Cancer Society]Eia ka papaʻaina maʻalahi e hōʻike ana i nā helu ola ola 5 makahiki ma ke kahua: ʻO ka pae i manaʻo ʻia he 5-makahiki ke ola ola ma ka ʻāina (ʻaʻole i laha ka maʻi kanesa ma waho o ka māmā) 59% Regional (ua laha ke kanesa i nā lymph nodes kokoke) 33% mamao (ua laha ka maʻi kanesa i nā kino mamao) 6% Nā pae āpau He mea nui kēia mau hopena e hoʻomanaʻo 25% nui. Noho me AdenocarcinomaLiving me adenocarcinoma hiki ke paʻakikī, akā aia nā kumuwaiwai e kōkua i nā maʻi a me ko lākou ʻohana e hoʻokō. Aia kēia mau kumuwaiwai: Nā pūʻulu kākoʻo Kūkākūkā mālama Palliative Therapies Integrative mālama i ke ola olakino, me ka ʻai kaulike a me ka hoʻoikaika mau, hiki ke hoʻomaikaʻi i ka maikaʻi o ke ola.ʻO ka mālama ʻana i ka maʻi kanesa adenocarcinoma ua holomua nui i nā makahiki i hala iho nei, e hāʻawi ana i nā maʻi i ʻoi aku ka maikaʻi a me nā koho pilikino. He mea koʻikoʻi ka hoʻomaopopo ʻana i ka maʻi, nā lāʻau lapaʻau i loaʻa, a me nā hopena ʻaoʻao no ka hoʻoholo ʻana. E kamaʻilio mau me kahi loea lapaʻau kūpono e hoʻomohala i ka maikaʻi ka mālama ʻana i ka maʻi maʻi ʻaʻai adenocarcinoma hoʻolālā no kāu kūlana pākahi. ʻO ka Shandong Baofa Cancer Research Institute ua hoʻolaʻa ʻia i ka hāʻawi ʻana i ka mālama piha a me ke aloha no nā maʻi me adenocarcinoma.